<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Nitrosamine Mutagenic Impurities Archives - Chemetrix</title>
	<atom:link href="https://chemetrix.co.za/tag/nitrosamine-mutagenic-impurities/feed/" rel="self" type="application/rss+xml" />
	<link>https://chemetrix.co.za/tag/nitrosamine-mutagenic-impurities/</link>
	<description>Powerful Partnership, Inspiring Insights</description>
	<lastBuildDate>Tue, 25 Oct 2022 13:41:52 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.3.6</generator>
	<item>
		<title>Analysis of Nitrosamine Impurities in Pharmaceuticals</title>
		<link>https://chemetrix.co.za/analysis-of-nitrosamine-impurities-in-pharmaceuticals/</link>
					<comments>https://chemetrix.co.za/analysis-of-nitrosamine-impurities-in-pharmaceuticals/#respond</comments>
		
		<dc:creator><![CDATA[Francois]]></dc:creator>
		<pubDate>Tue, 25 Oct 2022 13:32:56 +0000</pubDate>
				<category><![CDATA[Upcoming and New Events]]></category>
		<category><![CDATA[Webinar]]></category>
		<category><![CDATA[Analysis]]></category>
		<category><![CDATA[Nitrosamine Mutagenic Impurities]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[webinar]]></category>
		<guid isPermaLink="false">https://chemetrix.co.za/?p=4825</guid>

					<description><![CDATA[What you will learn Understand what mutagenic impurities are and why it’s important to characterize and quantify them, even when present in trace amounts. Understand the current regulatory guidelines for nitrosamines analysis in drug substance and product in Angiotensin II Receptor Blockers (sartan), ranitidine and metformin drugs Learn about approaches for the prevention of the &#8230; <a href="https://chemetrix.co.za/analysis-of-nitrosamine-impurities-in-pharmaceuticals/" class="more-link">Continue reading<span class="screen-reader-text"> "Analysis of Nitrosamine Impurities in Pharmaceuticals"</span></a>]]></description>
										<content:encoded><![CDATA[<h3>What you will learn</h3>
<ul>
<li>Understand what mutagenic impurities are and why it’s important to characterize and quantify them, even when present in trace amounts.</li>
<li>Understand the current regulatory guidelines for nitrosamines analysis in drug substance and product in Angiotensin II Receptor Blockers (sartan), ranitidine and metformin drugs</li>
<li>Learn about approaches for the prevention of the formation of GTIs and the confident identification and quantification of nitrosamines in APIs and drugs</li>
</ul>
<h3></h3>
<p>&nbsp;</p>
<h3>Who should attend</h3>
<ul>
<li>Laboratory managers</li>
<li>Chromatographers</li>
<li>Analytical chemists and scientists</li>
<li>New product developers</li>
<li>Pharma manufacturing and quality control managers</li>
</ul>
<p>&nbsp;</p>
<h3 class="section-header js-header data-section-label">Speaker</h3>
<div class="speaker-fields-container">
<div class="section">
<div class="sp-begin">
<h4><strong>Raman V.V.S.S. Nanduri, Ph.D.</strong><br />
Director,<br />
Analys Lab Pvt. Lt</h4>
</div>
<div class="sp-end">
<p>&nbsp;</p>
</div>
</div>
<h4><a href="https://www.agilent.com/en/training-events/eseminars/nitrosamines-mutagenic-impurities">Register and watch on demand &gt;</a></h4>
<p>&nbsp;</p>
</div>
]]></content:encoded>
					
					<wfw:commentRss>https://chemetrix.co.za/analysis-of-nitrosamine-impurities-in-pharmaceuticals/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Quality Control &#124; Nitrosamine Mutagenic Impurities</title>
		<link>https://chemetrix.co.za/quality-control-nitrosamine-mutagenic-impurities/</link>
					<comments>https://chemetrix.co.za/quality-control-nitrosamine-mutagenic-impurities/#respond</comments>
		
		<dc:creator><![CDATA[Ryno Swanepoel]]></dc:creator>
		<pubDate>Tue, 27 Jul 2021 12:27:51 +0000</pubDate>
				<category><![CDATA[Solution]]></category>
		<category><![CDATA[Nitrosamine Mutagenic Impurities]]></category>
		<category><![CDATA[Quality Control]]></category>
		<guid isPermaLink="false">http://chemetrix.co.za/?p=4050</guid>

					<description><![CDATA[Several drug products were recently recalled due to the presence of unacceptable amounts of mutagenic nitrosamine impurities. Chemetrix offers relevant GC/MS, LC/MS and high-throughput MS-based analytical technologies to accurately detect and quantify trace mutagenic and genotoxic impurities in drug products. &#160; Resources Nitrosamine Impurities Application Guide Application Guide Determination of Nitrosamine Impurities Using the Ultivo &#8230; <a href="https://chemetrix.co.za/quality-control-nitrosamine-mutagenic-impurities/" class="more-link">Continue reading<span class="screen-reader-text"> "Quality Control &#124; Nitrosamine Mutagenic Impurities"</span></a>]]></description>
										<content:encoded><![CDATA[<p>Several drug products were recently recalled due to the presence of unacceptable amounts of mutagenic nitrosamine impurities. Chemetrix offers relevant GC/MS, LC/MS and high-throughput MS-based analytical technologies to accurately detect and quantify trace mutagenic and genotoxic impurities in drug products.</p>
<p>&nbsp;</p>
<h2>Resources</h2>
<h4><strong>Nitrosamine Impurities Application Guide</strong></h4>
<p><strong><a href="http://chemetrix.co.za/wp-content/uploads/2021/07/Nitrosamine-and-Mutagenic-Impurities-Application-Guide.pdf" target="_blank" rel="noopener">Application Guide</a></strong></p>
<h4><strong>Determination of Nitrosamine Impurities Using the Ultivo Triple Quadrupole LC/MS</strong></h4>
<p><strong><a href="http://chemetrix.co.za/wp-content/uploads/2021/07/application-nitrosamine-impurities-ultivo-triple-quadrupole-lc-ms-5994-1383en-agilent.pdf" target="_blank" rel="noopener">Application Note</a></strong></p>
<h4><strong>Quantification of Nitrosamine Impurities in Metformin Using Agilent GC/MS/MS Instrumentation</strong></h4>
<p><strong><a href="http://chemetrix.co.za/wp-content/uploads/2021/07/application-nitrosamine-metformin-gc-ms-ms-5994-2419en-agilent.pdf" target="_blank" rel="noopener">Application Note</a></strong></p>
<h4><strong>Determine Nitrosamines Using LC/MS in Metformin-Based Drugs</strong></h4>
<p><strong><a href="http://chemetrix.co.za/wp-content/uploads/2021/07/application-nitrosamine-mutagenic-impurities-metformin-6470-lc-ms-tq-5994-2286en-agilent-1.pdf" target="_blank" rel="noopener">Application Note</a></strong></p>
<h4><strong>Determination of a Genotoxic NDMA Impurity Using the High-Resolution Agilent 6546 LC/Q-TOF in Ranitidine</strong></h4>
<p><strong><a href="http://chemetrix.co.za/wp-content/uploads/2021/07/application-pharmaceuticals-small-molecues-6546-q-tof-5994-1626en-agilent.pdf" target="_blank" rel="noopener">Application Note</a></strong></p>
]]></content:encoded>
					
					<wfw:commentRss>https://chemetrix.co.za/quality-control-nitrosamine-mutagenic-impurities/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
